Scalable adherent
cell processing for research and manufacturing
Facilitating faster, cheaper, and more sustainable production of cellular products.
Bioprocessing Solutions
CellRev’s continuous platform offers seamless translation from research to market with superior automation, control, and stability versus existing technologies.
Our patented biomanufacturing platform is founded on the ability to continuously grow, detach, and then collect adherent cells.
Applications include food, therapies, and biopharmaceuticals with data available on several cell lines including VERO, HACAT, and iPSCs.
We work with customers at any stage of process development to unlock bottlenecks in existing processes or commission our continuous platform. CellRev utilises a combination of their proprietary reagents and in-house process development expertise to design or improve adherent cell culture solutions for Biotech SMEs, CDMOs, and Biopharma manufacturers.
Benefits
3x increase
in bioreactor productivity
40-60% reduction
in labour costs
Up to 95% reduction
on single-use waste consumables
Up to 57% reduction
in CAPEX at scale
Applications
Food
Food
Cultivated Meat has multiple barriers to scaling such as fragmentation, cross-platform interoperability, and technology constraints.
CellRev work with producers to establish upstream bioprocesses that deliver significant operating cost reductions. We work alongside clients and engineering partners to provide a solution that can reduce the industrial footprint of this emergent field, while still achieving the scale needed to make it commercially viable.
Therapies
Therapies
Breakthroughs in cell therapies are fuelling a new wave of innovation, with the potential to save millions of lives.
CellRev assists with process development to remove bottlenecks in R&D and future-proof cell therapy manufacturing processes.
CellRev’s bioprocess translates seamlessly from research to commercial-scale manufacturing.
Biopharmaceuticals
Biopharmaceuticals
A more favourable regulatory environment is spurring innovation across the biopharma industry.
CellRev work with developers and manufacturers to optimise existing processes. In addition, the company can offer their continuous adherent cell culture platform to increase productivity, cost, and consistency of cell-based or cell-derived products.
Cultivated meat & seafood producers face countless scalability challenges, particularly as they strive to achieve price-parity with conventionally grown meat products.
The technologies developed by CellRev will be of critical importance in establishing cultivated meat as a realistic, viable, and attractive alternative to factory farming, meeting the world’s growing demand for food.
Progress continues to be made in allogeneic cell therapies, but with supply bottlenecks projected, it is still unknown how many of these life-saving solutions will make it to market in the coming years.
Our automated closed-loop system has the potential to provide superior cell expansion solutions in the years ahead.
Progress continues to be made in allogeneic cell therapies, but with supply bottlenecks projected, it is still unknown how many of these life-saving solutions will make it to market in the coming years.
Our automated closed-loop system has the potential to provide superior cell expansion solutions in the years ahead.
Food
Food
Cultivated Meat has multiple barriers to scaling such as fragmentation, cross-platform interoperability, and technology constraints.
CellRev work with producers to establish upstream bioprocesses that deliver significant operating cost reductions. We work alongside clients and engineering partners to provide a solution that can reduce the industrial footprint of this emergent field, while still achieving the scale needed to make it commercially viable.
Therapies
Therapies
Breakthroughs in cell therapies are fuelling a new wave of innovation, with the potential to save millions of lives.
CellRev assists with process development to remove bottlenecks in R&D and future-proof cell therapy manufacturing processes.
CellRev’s bioprocess translates seamlessly from research to commercial-scale manufacturing.
Biopharmaceuticals
Biopharmaceuticals
A more favourable regulatory environment is spurring innovation across the biopharma industry.
CellRev work with developers and manufacturers to optimise existing processes. In addition, the company can offer their continuous adherent cell culture platform to increase productivity, cost, and consistency of cell-based or cell-derived products.
CellRev’s continuous cell processing platform is compatible with all adherent cell culture processes.
Contact us to discuss your requirements.
Our Partners
News and Insight
To stay up to date with our latest product updates and innovations, join our mailing list below.
Cell culture is at the cutting edge of biological innovation. However, the need to reach commercial scale presents many practical, scientific, regulatory, …
At CellRev, we are working towards a bright future for adherent cell culture across industries such as cultured meat and seafood, cell …
The global food supply chain faces a perfect storm of threats in the coming decades. From climate change to population growth, concerns …
Continuous processing is not new and is being adopted by more and more industries as they acknowledge the inherent limitations of batch …
CellRev has developed a revolutionary new approach to adherent cell culture, promising to transform the commercial potential of this nascent field. The …
Cell culture is at the cutting edge of biological innovation. However, the need to reach commercial scale presents many practical, scientific, regulatory, …
At CellRev, we are working towards a bright future for adherent cell culture across industries such as cultured meat and seafood, cell …
The global food supply chain faces a perfect storm of threats in the coming decades. From climate change to population growth, concerns …
Continuous processing is not new and is being adopted by more and more industries as they acknowledge the inherent limitations of batch …
Cell culture is at the cutting edge of biological innovation. However, the need to reach commercial scale presents many practical, scientific, regulatory, …
At CellRev, we are working towards a bright future for adherent cell culture across industries such as cultured meat and seafood, cell …
The global food supply chain faces a perfect storm of threats in the coming decades. From climate change to population growth, concerns …
